Dexamethasone reduces infusion-related reactions in patients with EGFR -mutated non-small cell lung cancer treated with intravenous RYBREVANT ® (amivantamab-vmjw)
...pain (47%), stomatitis (43%), edema (43%), VTE (36%), paresthesia (35%), fatigue (32%), diarrhea (31%), constipation (29%), COVID-19 (26%), hemorrhage (25%), dry skin (25%), decreased appetite (24%), pruritus (24%), nausea (21%), and ocular toxicity...
Zur Pressemeldung auf www.jnj.com